Screener
PBL
Parabilis Medicines
PBLSParabilis Medicines is a biotechnology company in the healthcare sector trading on XNAS, led by CEO Mathai Mammen, with a market cap of $3.8B.
Earnings
Next report
Feb 11, 2027 (in 3 months)Revenue estimate$1.1M
EPS estimate-$0.42
Financials
Q3 2026Valuation & ratios
Profile
CountryUnited States of America
Listed2026
CEOMathai Mammen
SectorHealthcare
IndustryBiotechnology
Websiteparabilismed.com
FilingsSEC EDGAR
FAQ
- What is Parabilis Medicines's market cap?
- Parabilis Medicines (PBLS) has a market capitalization of $3.8B and trades on XNAS.
- Where is Parabilis Medicines headquartered?
- Parabilis Medicines is headquartered in United States of America. It has been publicly traded since 2026.